Previous 10 | Next 10 |
Don’t Believe In Penny Stocks? This Might Make You Think Twice What comes to mind when you think about penny stocks ? Low price stock, B.S. companies, or maybe even long-shot lottery tickets? There’s no right or wrong answer to this question but there is an answer to the next qu...
Quick Take iTeos Therapeutics ( ITOS ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The company is a clinical stage biopharma firm advancing a pipeline of immuno-oncology drug candidates for treating solid tumors and other can...
Compugen Received FDA Clearance of IND Application Compugen ( CGEN ) announced that the FDA has given its clearance for the Investigational New Drug for Phase 1/2 study of its Triple combination therapy for cancer. The company expects to initiate the trial during the second half of the yea...
The FDA has cleared Compugen's (NASDAQ: CGEN ) investigational new drug (IND) application for Phase 1/2 study evaluating the triple combination of Compugen's COM701, an anti-PVRIG antibody, Opdivo (nivolumab), Bristol Myers Squibb's (NYSE: BMY ) PD-1 immune checkpoint inhibitor and BM...
HOLON, Israel , June 1, 2020 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the U.S. Food and Drug Administration has cleared the investigational new drug (IND) app...
HOLON, Israel , May 27, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the first patient has been dosed in the monotherapy expansion cohort of its ongoing Phase 1 cli...
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. For investors who can master the discipline and pick out the right stocks, a lot of money can be made. Today, let's examine two o...
Gainers: Applied DNA Sciences (NASDAQ: APDN ) +51% . More news on: Applied DNA Sciences, Inc., Akers Biosciences, Inc., Glory Star New Media Group Holdings Limited, Stocks on the move, , Read more ...
Data by YCharts Based in Holon, Israel with R&D facilities located in both Israel and South San Francisco, California, Compugen Ltd. (NASDAQ: CGEN ) is a clinical-stage cancer immunotherapy company, a leader in computational predictive target discovery which has focused on internal...
The following slide deck was published by Compugen Ltd. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors PR Newswire FDA clearance triggers a $30 million milestone payment from Gilead Company on track to initiate a Phase 1 trial for COM503, a differentiated antibody approach to harne...
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 PR Newswire HOLON, Israel , July 23, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target ...
Compugen to Present at Upcoming Antibody Industrial Symposium PR Newswire HOLON, Israel , June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, t...